FRA:NOVC - Deutsche Boerse Ag - DK0060534915 - Common Stock - Currency: EUR
The current stock price of NOVC.DE is 86.34 EUR. In the past month the price decreased by -49.3%. In the past year, price decreased by -13.99%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
LLY.DE | ELI LILLY & CO | 68.77 | 810.81B | ||
1LLY.MI | ELI LILLY & CO | 67.23 | 792.68B | ||
ZEG.DE | ASTRAZENECA PLC | 20.75 | 440.83B | ||
NOV.DE | NOVO NORDISK A/S-B | 27.58 | 374.66B | ||
JNJ.DE | JOHNSON & JOHNSON | 16.2 | 372.41B | ||
1JNJ.MI | JOHNSON & JOHNSON | 15.99 | 367.60B | ||
SNW.DE | SANOFI | 13.56 | 261.10B | ||
SAN.PA | SANOFI | 13.56 | 261.05B | ||
1SAN.MI | SANOFI | 13.55 | 260.85B | ||
6MK.DE | MERCK & CO. INC. | 11.64 | 215.02B | ||
1MRKX.MI | MERCK & CO. INC. | 11.12 | 205.41B | ||
PFE.DE | PFIZER INC | 8.4 | 141.39B |
Novo Nordisk A/S is a DK-based company operating in Pharmaceuticals industry. Novo Nordisk A/S is a global healthcare company engaged in diabetes care. The firm is also engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The firm operates through two business segments: diabetes and obesity care, and biopharmaceuticals. The firm's diabetes and obesity care segment covers insulin, GLP-1, other protein-related products, such as glucagon, protein-related delivery systems and needles, and oral anti-diabetic drugs. The firm's biopharmaceuticals segment covers the therapy areas of hemophilia care, growth hormone therapy and hormone replacement therapy. The firm also offers Saxenda product to treat obesity. The company offers a range of products, including NovoLog/NovoRapid; NovoLog Mix/NovoMix; Prandin/NovoNorm; NovoSeven; Norditropin, and Vagifem. As of December 31, 2016, it marketed its products in over 180 countries. Its regional structure consists of two commercial units: North America and International Operations.
Novo Alle 1
Bagsvaerd DK
Employees: 59337
Company Website: https://www.novonordisk.com/
Phone: 4544448888.0
The current stock price of NOVC.DE is 86.34 EUR. The price decreased by -2.3% in the last trading session.
The exchange symbol of is NOVC and it is listed on the Deutsche Boerse Ag exchange.
NOVC.DE stock is listed on the Deutsche Boerse Ag exchange.
32 analysts have analysed NOVC.DE and the average price target is 169.94 EUR. This implies a price increase of 96.83% is expected in the next year compared to the current price of 86.34. Check the stock analysts ratings, price target forecast and up-and down grades for more detailed information.
(NOVC.DE) has a market capitalization of 386.28B EUR. This makes NOVC.DE a Mega Cap stock.
(NOVC.DE) currently has 59337 employees.
The Revenue of (NOVC.DE) is expected to grow by 27.56% in the next year. Check the estimates tab for more information on the NOVC.DE EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
NOVC.DE does not pay a dividend.
The PE ratio for (NOVC.DE) is 43.17. This is based on the reported non-GAAP earnings per share of 2 and the current share price of 86.34 EUR. Check the full fundamental report for a full analysis of the valuation metrics for NOVC.DE.
ChartMill assigns a fundamental rating of 7 / 10 to NOVC.DE. NOVC.DE gets an excellent profitability rating and is at the same time showing great financial health properties.
Over the last trailing twelve months NOVC.DE reported a non-GAAP Earnings per Share(EPS) of 2. The EPS decreased by -32.68% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 33.4% | ||
ROA | 23.95% | ||
ROE | 74.32% | ||
Debt/Equity | 0.21 |
ChartMill assigns a Buy % Consensus number of 71% to NOVC.DE. The Buy consensus is the average rating of analysts ratings from 32 analysts.
For the next year, analysts expect an EPS growth of 96.77% and a revenue growth 27.56% for NOVC.DE